Freedberg Jared - Insider Non-Derivative Transactions at INTERCEPT PHARMACEUTICALS, INC. (ICPT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Nov 8, 2023, Freedberg Jared's relationship to INTERCEPT PHARMACEUTICALS, INC. (ICPT) is Officer (General Counsel), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ICPT insiders.

Data Source: SEC.
Freedberg Jared - Insider Non-Derivative Transactions of ICPT Common Stock
Freedberg Jared - Insider Non-Derivative Transactions at ICPT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Nov 9, 2023 Disposition -- (Common Stock) 33762 19 0
Nov 9, 2023 U -- (Common Stock) 22681 19 0
Nov 2, 2023 F -- (Common Stock) 771 18.96 56443
Aug 2, 2023 F -- (Common Stock) 771 10.5 57214
May 2, 2023 F -- (Common Stock) 771 17.07 57985
Feb 2, 2023 F -- (Common Stock) 918 18.76 58756
Jan 28, 2023 Acquisition -- (Common Stock) 12200 0 59674
Jan 1, 2023 F -- (Common Stock) 718 12.37 47474